我不是药神也不是股神
12-05
$QUANTUMPH-P(02228)$
全球AI设计药物商业化进展平均来说没能达到资本的预期,但晶泰科技在这方面的成绩已经领先了大多数的同行企业了,还是受资本关注的
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":378235181928880,"tweetId":"378235181928880","gmtCreate":1733385303007,"gmtModify":1733385304342,"author":{"id":3564011840073775,"idStr":"3564011840073775","authorId":3564011840073775,"authorIdStr":"3564011840073775","name":"我不是药神也不是股神","avatar":"https://static.tigerbbs.com/a37cb08394c3dc27fb59f07921d7c74f","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02228\">$QUANTUMPH-P(02228)$</a> 全球AI设计药物商业化进展平均来说没能达到资本的预期,但晶泰科技在这方面的成绩已经领先了大多数的同行企业了,还是受资本关注的</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02228\">$QUANTUMPH-P(02228)$</a> 全球AI设计药物商业化进展平均来说没能达到资本的预期,但晶泰科技在这方面的成绩已经领先了大多数的同行企业了,还是受资本关注的</p></body></html>","text":"$QUANTUMPH-P(02228)$ 全球AI设计药物商业化进展平均来说没能达到资本的预期,但晶泰科技在这方面的成绩已经领先了大多数的同行企业了,还是受资本关注的","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/378235181928880","repostId":0,"isVote":1,"tweetType":1,"viewCount":455,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02228"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":140,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/378235181928880"}
精彩评论